5th International Workshop on the Biology, Prevention, and Treatment of Relapse after Hematopoietic Stem Cell Transplant

New York, NY US
October 8, 2021 to October 9, 2021
Are you a medical or pediatric hematologist-oncologist, hematopoietic stem and immune cell translational and basic scientist, hematopathologist, physician-in-training, advance practice provider, pharmacist, oncology nurse. or other associated healthcare professional? If so, you should consider joining us on October 8-9, 2021, in New York City!
Relapse and disease progression are the leading causes of treatment failure for most hematologic malignancies treated with both allogeneic and autologous hematopoietic stem cell transplantation. During the last 5 years significant advances have been made in our understanding of the biology of relapse such as understanding the role of HLA loss in leukemia recurrence post-transplant. Since our 1st relapse meeting we now have three drugs approved to prevent disease recurrence post autologous transplant, and the role of FLT3 inhibitors and other TKIs to prevent relapse post allogeneic HCT is actively ongoing. Finally, the efficacy of CD 19 CAR T-cell therapy for patients with disease relapsing after HCT has been firmly established for ALL and NHL.
The Fifth International Workshop on Biology, Prevention and Treatment of Relapse After Hematopoietic Stem Cell Transplantation and Cellular Therapy (HSCT²)  will gather the leaders in the field to update us on these issues as well as novel mechanisms of relapse that have recently been described and discovered. As a workshop participant, you will benefit from the knowledge of internationally recognized speakers from a diverse multidisciplinary group comprised of basic and translational scientists and clinical investigators. Tremendous progress in treatment research has been made over the recent past years, and we are eager to share it with you.
The Fifth International Workshop on Biology, Prevention and Treatment of Relapse After Hematopoietic Stem Cell Transplantation and Cellular Therapy (HSCT²)  will take place at the first-class, centrally located Grand Hyatt New York in Midtown Manhattan. The Organizing Committee is working diligently to make this Fifth International Workshop a truly valuable experience for all participants. We look forward to learning alongside you and welcoming you to the vibrant, captivating city of New York.
For more information, visit the conference website!

Target Audience

This activity is designed for medical and pediatric hematologists and oncologists, hematopoietic stem and immune cell translational and basic scientists, hematopathologists, physicians-in-training, advance practice providers, pharmacists, oncology nurses and other healthcare professionals dedicated to providing the highest level of care in hematopoietic stem cell transplantation.

Learning Objectives

At the conclusion of this course, participants will be able to:

  • State the basic mechanisms of relapse after transplant and cellular therapies;
  • Recognize risk factors for relapse after transplant and cellular therapies;
  • Identify strategies to prevent relapse after transplant and cellular therapies;
  • Identify treatment strategies that can be used to treat patients who have relapsed after transplant;
  • Recognize the importance of clinical trials in this patient population.
Additional information
ACGME/ABMS Core Competencies: 
Patient Care and Procedural Skills
Medical Knowledge
Practice-based Learning and Improvement
For more information, please contact:
CME Coordinator Contact Name: 
Sara Baratta
CME Coordinator Contact Email: 
CME Coordinator Contact Phone: 
PDF icon Invitation Letter166.18 KB
PDF icon Features Experts145.58 KB
PDF icon Conference Benefits202.8 KB
Available credit: 
  • 15.75 AMA PRA Category 1 Credit™
  • 15.75 Participation
Event starts: 
10/08/2021 - 8:00am
Event ends: 
10/09/2021 - 4:30pm
Activity opens: 
Activity expires: 
Relapse 2021 Agenda
Relapse 2021 Agenda
Relapse 2021 Agenda
Relapse 2021 Agenda
Sheraton New York Times Square
811 Seventh Avenue
New York, NY 10019
United States

Learners can attend this event in-person or virtually. For questions about the event, contact Sara Baratta via e-mail.


Discover an urban retreat in the heart of Midtown NYC at Sheraton New York Times Square Hotel. This hotel offers intuitively designed guest rooms, where perks like high-speed Wi-Fi, luxurious bedding and deluxe amenities await. Break a sweat in the 4,000-square-foot, state-of-the-art fitness center or dine on delicious market-inspired cuisine at Hudson Market, the signature hotel restaurant. Sip on cocktails or Starbucks® coffees at the sophisticated Library Bar, and work productively in the on-site business center. 

New York City, known as "the City that Never Sleeps," offers year-round entertainment at all hours of the day, and this Midtown location puts guests right where they need to be. With world-famous shops, restaurants, and museums on your doorstep, the Sheraton New York Times Square is the perfect home base for your  NYC adventure.

To learn more about accommodations, visit the conference website below!


ACCESSIBILITY The University of Chicago is committed to providing equal access appropriate to need and circumstances and complies fully with legal requirements of the Americans with Disabilities Act. If you are in need of special accommodation, please contact Sara Baratta at 630-776-3934 or via email at HSCTconference@mocandco.com.

The University of Chicago reserves the right to cancel or postpone this conference due to unforeseen circumstances. In the unlikely event this activity must be cancelled or postponed, the registration fee will be refunded; however, The University of Chicago is not responsible for any related costs, charges, or expenses to participants, including fees assessed by airline/travel/lodging agencies.

Michael R. Bishop, MD  Michael Bishop, MD
  Professor of Medicine
  Director, Hematopoietic Stem Cell Transplantation Program
  University of Chicago

Alan Wayne, MD  Alan Wayne, MD
  Director, Cancer and Blood Disease Institute
  Head, Division of Hematology-Oncology
  Attending Physician, Hematology-Oncology
  Alfred E. Mann Family Foundation Chair in Cancer Research
  Professor of Pediatrics and Medicine
                         University of Southern California
Sergio Giralt, MD  Sergio Giralt, MD
  Deputy Division Head, Division of Hematologic Malignancies
  Melvin Berlin Family Chair in Multiple Myeloma
  Memorial Sloan Kettering Cancer Center

Nicolaus Kröger, MD  Nicolaus Kröger, MD
  Director, Department of Stem Cell Transplantation
  University Hospital Hamburg

Disclosure Declarations
As a provider accredited by the ACCME, The University of Chicago Pritzker School of Medicine asks everyone who is in a position to control the content of an education activity to disclose all relevant financial relationships with any commercial interest. This includes any entity producing, marketing, re-selling, or distributing health care goods or services consumed by or used on patients. The ACCME defines “relevant financial relationships” as financial relationships in any amount occurring within the past 12 months, including financial relationships of a spouse or life partner that could create a conflict of interest. Mechanisms are in place to identify and resolve any potential conflict of interest prior to the start of the activity.

Additionally, The University of Chicago Pritzker School of Medicine requires authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration, at first mention and where appropriate in the content.

Physician Credit
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of The University of Chicago Pritzker School of Medicine and the Organizing Committee. The University of Chicago Pritzker School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.
The University of Chicago Pritzker School of Medicine designates this live activity for a maximum of 15.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Other Healthcare Professions Credit
Other healthcare professionals will receive a Certificate of Participation. For information on the applicability and acceptance of Certificates of Participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by the ACCME, please consult your professional licensing board.
European Union of Medical Specialties
The American Medical Association (AMA) has an agreement of mutual recognition of continuing medical education (CME) credit with the European Union of Medical Specialties (UEMS). International physicians interested in converting AMA PRA Category 1 Credit™ to EACCME credit should contact the UEMS.
This conference offers a tremendous opportunity to highlight your company products, services, and achievements in front of a wide array of key decision makers. Increase your company profile by participating as an exhibitor at this exciting event.
We are pleased to provide a number of opportunities for organizations to advertise their products and services to conference participants. Whether you are chatting with an attendee about the elements at your exhibit booth, connecting with physicians during one of the scheduled breaks, or gaining brand recognition for your company through program acknowledgements, your message will reach physicians, nurses, and other healthcare professionals.
Download the prospectus PDF icon here or contact Sara Baratta at HSCTconference@mocandco.com or 630-338-8517. We hope to see you there!

Chicago Autumn


Registration is now open! Click the button below to get started.

Profession Type
Physicians & Scientists
Other Healthcare Professionals



After creating an account or logging in, enter the access code to unlock the credit claiming process.

Please login or create an account to proceed.